Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 3132 of 5804
-
Barrett's esophagus treatment showdown: which procedure hurts less?
Disease control CompletedThis study compares patients' acceptability and safety of two established endoscopic methods for treating dysplastic Barrett's esophagus: radiofrequency ablation versus hybrid argon plasma coagulation.
Phase: NA • Sponsor: Centre of Postgraduate Medical Education • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Heart surgery showdown: which bypass method spares tiny vessels?
Knowledge-focused CompletedThe aim of the proposed study is to evaluate microcirculatory alterations in patients undergoing open heart surgery with minimal invasive versus conventional extracorporeal circulation.
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Fiber fix for peanut allergy? small study tests prebiotic boost to OIT
Disease control CompletedThe purpose of this research is to gather information on the safety and efficacy of using a prebiotic as an adjunctive therapy to peanut oral immunotherapy. The prebiotic is not an FDA approved drug or medication rather a fiber found at local grocery stores.
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study tracks Long-Term safety of rare disease treatment
Disease control OngoingThe primary objective of this study is to assess the long-term safety, including pregnancy, infant, and lactation outcomes, of patients with LC-FAOD who are enrolled in the DMP.
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New melasma cream may offer same results with fewer side effects
Symptom relief CompletedKligman's trio remains the gold standard treatment for melasma. It contain hydroquinone which is an effective anti-melanogenic compound but that has poor tolerance and numerous side-effects. Thiamidol has been proven to be at least as effective as hydroquinone and has a very good…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can your pulse oximeter be trusted? new study tests accuracy across skin tones
Knowledge-focused Recruiting nowThe aim of this project is to test the accuracy of pulse oximeters during mild, moderate and severe hypoxia. This is done by comparing the reading of the pulse oximeter during brief, steady state hypoxia with a gold-standard measurement of blood oxygen. This study will be done on…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:40 UTC
-
Asthma Drug's hidden effects revealed in small study
Knowledge-focused CompletedUnderstanding how Interleukin-5 blockade modulates both immune and metabolic pathways may clarify the multidimensional impact of biologic therapy in severe eosinophilic asthma. Therefore, this study aimed to assess the impact of mepolizumab on the nasal, bronchial, and systemic m…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Heart study seeks optimal stent timing after artery reopening
Knowledge-focused CompletedSTAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with ra…
Phase: NA • Sponsor: Saint Luke's Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
IVF debate: does less stimulation mean better embryos?
Knowledge-focused CompletedThe management of suboptimal ovarian responders remains a challenging task in IVF. These patients are frequently managed with an intense stimulation protocol of ovarian stimulation in order obtain the maximum number of embryos and, therefore, maximize the cumulative live birth ra…
Phase: PHASE4 • Sponsor: Fundación Santiago Dexeus Font • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy tackles cancer in HIV patients
Disease control OngoingThis phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and who are undergoing treatment for human immun…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
App and coaching help men stick with HIV prevention pill
Disease control CompletedThe study is a prospective cohort of young MSM who are followed for 2 years either in-person at the PRISM Health Research Clinic and/or virtually with telehealth study visits. Follow-up visits occur as frequently as every 3 months, or as appropriate to clinical needs of HIV PrEP …
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Brain scan breakthrough could spot MS cognitive decline early
Knowledge-focused ENROLLING_BY_INVITATIONThe overall purpose of this research is to determine whether new macromolecular measures optimized for whole brain (gray matter and white matter) magnetic resonance imaging (MRI), predict neuro-cognitive impairment in multiple sclerosis (MS) patients.
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Can a dementia drug silence ringing ears?
Symptom relief OngoingThis study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first mon…
Phase: PHASE4 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 26, 2026 14:20 UTC
-
New combo therapy for blood cancers shows promise in early trial
Disease control CompletedThe purpose of the study is to find a safe dose and to evaluate the safety and tolerability of the drug BMS-986345, in combination with duvelisib.
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Breathing app aims to ease cancer Survivors' symptoms
Symptom relief CompletedCancer survivorship is associated with many long-term chronic health issues that arise as a result of cancer treatment protocols. Non-pharmacological lifestyle and mind-body interventions have been shown to be effective and critical components of a total-health strategy for cance…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Liver cancer drug safety checked in 263 patients
Disease control CompletedThis study is a survey in Japan of Cabozantinib tablets used to treat Japanese people with a type of liver cancer called hepatocellular carcinoma. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will reco…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Texts and cash incentives get teens moving in prediabetes study
Symptom relief CompletedThere is an urgent need to engineer targeted physical activity interventions that are effective and scalable for obese adolescents and young adults (AYA) with type 2 diabetes (T2D), who often have very low levels of physical activity. The BEAM Trial is a mobile health (mHealth) i…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New program offers hope for chronic back pain sufferers
Symptom relief CompletedThis study evaluated the effects of a multidisciplinary biopsychosocial program compared with standard multimodal care in patients with chronic low back pain treated at the University Hospital Osijek. Outcomes included pain intensity, disability, health-related quality of life, a…
Phase: NA • Sponsor: Osijek University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Sleep smarter, sugar lower? new study tests sleep education for diabetes
Symptom relief CompletedThe aim of this study is to evaluate the effect of sleep hygiene education on sleep quality and glycemic control of Type 2 Diabetes patients. Patients between the ages of 18-65, who were registered to the Gaziemir 11 No. Dokuz Eylül Education Family Health Centers and applied to …
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New 3D ultrasound aims to sharpen breast cancer detection
Diagnosis Recruiting nowThe purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC